Project Grant R15EY031539

Award Date 9/30/22
Completion Date 5/31/26
Dollars Obligated $839K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $589,212 to the University of California, Santa Cruz to investigate the developmental mechanisms underlying the integration of visual and auditory spatial information, and how this process impacts natural spatial orienting behaviors. The key objectives are to determine the critical period for multisensory integration (MSI) development, quantify how changes in...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,505,818 to Rosalind Franklin University of Medicine & Science to investigate the role of the neurexin protein in social behavior and amygdala plasticity. The research aims to determine how disruptions in the neurexin 1 gene, which is associated with autism spectrum disorder (ASD), impact the prefrontal cortex-amygdala neural circuit...
This $718,662 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research to characterize the genetic regulation of alternative polyadenylation (APA) in the developing human brain and its contribution to neuropsychiatric disorders like autism spectrum disorder (ASD) and schizophrenia (SCZ). The project aims to generate a comprehensive atlas of APA regulation across neurodevelopment, leveraging data from...
This $2,308,368 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) supports research to investigate the relationship between visual attention, multimodal communication cues, and expressive language development in typically developing children and those with autism spectrum disorder (ASD). The research, led by Vanderbilt University Medical Center, will leverage existing datasets and conduct new...
This $641,726 federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), aims to investigate the role of neuronal and immune system dysfunction in auditory system deficits associated with autism spectrum disorders (ASDs). The key objectives are to: 1) characterize the expression patterns of the ASD risk gene MEF2C in spiral ganglion neurons and cochlear...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $196,597 to The Regents of the University of California, San Francisco (UCSF) to determine the changes to information processing and neural activity in the hippocampus associated with a high-risk autism spectrum disorder (ASD) gene in rats. The research aims to establish a clear behavioral phenotype consistent with restrictive and...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $187,431 to the University of North Carolina at Chapel Hill to determine whether early life sleep disruption interacts with distinct genetic vulnerabilities associated with autism spectrum disorder (ASD). The key objectives are to establish if early life sleep disruption is a risk factor contributing to ASD susceptibility by interacting with...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $251,250 to The Feinstein Institutes for Medical Research to study sex-dependent dysregulation of parvalbumin interneurons as a pathway to autism spectrum disorder (ASD). The key objectives are to: 1) Determine if the reduction in parvalbumin-expressing interneurons observed in male mice exposed in utero to anti-CASPR2 antibodies is associated with...
This Federal Project Grant award of $116,798 from the National Institute of Mental Health (NIMH) under CFDA 93.242 (Mental Health Research Grants) supports research to evaluate the impact of the autism risk gene FOXP1 on early neocortical development, specifically examining its effects on neuronal migration and cell fate. The key objectives of this 2-year project are to 1) determine how FOXP1 loss disrupts radial migration of upper layer neuronal subtypes and 2) assess how FOXP1 loss impacts the...
This Project Grant award from the National Institute of Mental Health (NIMH), under the federal Mental Health Research Grants program (CFDA 93.242), provides $194,375 to the University of Wisconsin-Madison to conduct research on the role of midbody remnants (MBRs) in influencing cortical development and cell fate decisions in the context of autism spectrum disorder (ASD). The key objectives of this 2-year research project are to: 1) Determine how an ASD-associated PTEN mutation alters the...

GENETIC AND CIRCUIT CONTROL OF VISUO-ACOUSTIC BEHAVIOR AND INTEGRATION - FUNCTION-DISRUPTING AP2S1 ALLELES HAVE RECENTLY BEEN LINKED TO LEARNING DISABILITIES AND AUTISM SPECTRUM DISORDERS (ASD), THOUGH THE MECHANISMS UNDERLYING THIS GENE'S IMPACT ON HUMAN BEHAVIOR ARE UNKNOWN. UNDERSTANDING HOW, WHEN, AND WHERE THIS GENE REGULATES VERTEBRATE BEHAVIOR IS KEY TO ADDRESSING DEFICITS OBSERVED IN THESE AND OTHER NEUROPSYCHIATRIC CONDITIONS, YET VIABLE VERTEBRATE MODELS ARE LACKING. OUR LAB HAS ISOLATED VIABLE ZEBRAFISH AP2S1 MUTANTS AND HAS BEGUN TO CHARACTERIZE AP2S1'S ROLE IN COGNITIVE PROCESSES SUCH AS INTEGRATING MULTISENSORY INFORMATION, APPROPRIATE SELECTION OF BEHAVIORS, AND HABITUATION LEARNING. GIVEN THAT DEFICITS IN INFORMATION PROCESSING AND BEHAVIORAL SELECTION ARE CHARACTERISTICS SHARED BY MANY NEUROPSYCHIATRIC CONDITIONS, INCLUDING ASD AND SCHIZOPHRENIA, OUR GENETICALLY-ACCESSIBLE MODEL CAN BE LEVERAGED TO DETERMINE THE MOLECULAR AND NEURAL MECHANISMS UNDERLYING THESE CONDITIONS AS WELL AS MORE BROADLY CHARACTERIZE AP2S1'S ROLE IN MULTISENSORY INTEGRATION, BEHAVIOR SELECTION, AND LEARNING. WE WILL USE OUR ZEBRAFISH MODEL TO REVEAL THE NEURAL MECHANISMS BY WHICH AP2S1 MODULATES VISUAL AND ACOUSTIC BEHAVIOR AND SENSORY INTEGRATION. IN AIM 1, WE WILL DETERMINE WHAT ASPECTS OF VISUALLY GUIDED LEARNING, VISUAL BEHAVIOR SELECTION, AND VISUO-ACOUSTIC INTEGRATION REQUIRE AP2S1. OUR RESULTS WILL TEST THE HYPOTHESIS THAT AP2S1 DIRECTLY MODULATES VISUAL PROCESSING AND VISUO-ACOUSTIC INTEGRATION, BEYOND ITS ROLE IN ACOUSTIC BEHAVIOR. IN AIM 2, WE WILL DETERMINE THE TEMPORAL AND SPATIAL REQUIREMENTS FOR AP2S1 TO MODULATE VISUALLY AND ACOUSTICALLY EVOKED BEHAVIOR USING INDUCIBLE AND CELL-SPECIFIC TRANSGENES. OUR RESULTS WILL TEST THE HYPOTHESES THAT THE BEHAVIORAL ROLE OF AP2S1 IS 1) TO REGULATE APPROPRIATE CIRCUIT DEVELOPMENT, AND/OR 2) TO REGULATE ACUTE NEURONAL FUNCTION, AND WILL DISTINGUISH IF AP2S1 REGULATES VISUAL AND ACOUSTIC RESPONSES THROUGH DISTINCT OR SHARED CIRCUITS. IN AIM 3, WE WILL FOCUS ON THE PAIR OF COMMAND-LIKE MAUTHNER NEURONS THAT INTEGRATE VISUAL AND ACOUSTIC INFORMATION TO DRIVE ESCAPE BEHAVIOR, AND DETERMINE HOW ITS FUNCTION IS MODULATED BY AP2S1. THROUGH SUBCELLULAR CALCIUM IMAGING IN BEHAVING FISH, OUR RESULTS WILL TEST THE HYPOTHESIS THAT AP2S1 MODULATES ESCAPE BEHAVIOR SELECTION THROUGH A SPATIALLY-SPECIFIC IMPACT ON MAUTHNER DENDRITIC INTEGRATION, REVEALING THE DYNAMICS OF VISUAL AND ACOUSTIC INFORMATION INTEGRATION IN THESE CENTRAL NEURONS. OVERALL, THESE AIMS WILL POSITIVELY IMPACT HUMAN HEALTH INITIATIVES BY ADVANCING OUR KNOWLEDGE OF THE GENETIC AND NEURAL MECHANISMS GOVERNING MULTISENSORY INFORMATION PROCESSING AND BEHAVIORAL SELECTION, AND THE DIRECT ROLES OF THE ASD-LINKED GENE AP2S1. FURTHERMORE, OUR PROPOSED WORK WILL VALIDATE THE USE OF THESE BEHAVIORAL ASSAYS AS A ZEBRAFISH MODEL FOR VERTEBRATE MULTISENSORY INTEGRATION THAT WILL BE USED TO CHARACTERIZE OTHER GENES AS THEY BECOME CLINICALLY RELEVANT.

Posted 9/20/22, 12:00 AM